Valuation China Resources Pharmaceutical Group Limited

Stocks

Market Closed - Hong Kong S.E. 12:08:32 18/09/2026 +04			5-day change	1st Jan Change
4.350 ^HKD	+1.75%		+2.35%	-2.25%

09-01	China Resources Pharma Unit's Bond Program Registration Accepted in China	MT
08-24	China Resources Pharmaceutical Group Limited Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	22,303	39,705	32,229	35,810	27,957	27,329	-	-
Change	-	78.03%	-18.83%	11.11%	-21.93%	-2.25%	-	-
Enterprise Value (EV) ¹	61,337	73,426	71,468	90,725	90,801	76,564	69,857	57,550
Change	-	19.71%	-2.67%	26.95%	0.08%	-15.68%	-8.76%	-17.62%
P/E	5.92x	9.58x	7.76x	10x	6.12x	5.58x	5.24x	5x
PBR	0.44x	0.8x	0.32x	0.34x	0.48x	0.42x	0.39x	0.35x
PEG	-	1x	44.15x	-0.7x	0.2x	0.77x	0.8x	1.02x
Capitalization / Revenue	0.09x	0.16x	0.12x	0.13x	0.09x	0.08x	0.08x	0.08x
EV / Revenue	0.26x	0.29x	0.27x	0.33x	0.3x	0.23x	0.21x	0.16x
EV / EBITDA	4.83x	4.38x	4.65x	5.47x	4.73x	3.81x	3.26x	2.78x
EV / EBIT	6.22x	5.39x	5.98x	6.98x	6.23x	4.75x	4.02x	3.28x
EV / FCF	5.88x	7.47x	5.49x	5.73x	4.37x	-28.2x	9.52x	6.38x
FCF Yield	17%	13.4%	18.2%	17.5%	22.9%	-3.55%	10.5%	15.7%
Dividend per Share ²	0.15	0.16	0.1669	0.1445	0.2203	0.2035	0.2202	0.218
Rate of return	4.23%	2.53%	3.25%	2.54%	4.95%	4.68%	5.06%	5.01%
EPS ²	0.6	0.66	0.6612	0.5677	0.7268	0.7792	0.83	0.8706
Distribution rate	25%	24.2%	25.2%	25.5%	30.3%	26.1%	26.5%	25%
Net sales ¹	236,806	254,106	265,229	275,999	306,131	327,766	340,287	351,655
EBITDA ¹	12,690	16,775	15,382	16,601	19,202	20,083	21,457	20,701
EBIT ¹	9,868	13,623	11,952	13,005	14,567	16,129	17,398	17,536
Net income ¹	3,769	4,147	4,178	3,589	4,594	4,817	5,171	5,365
Net Debt ¹	39,035	33,720	39,238	54,915	62,844	49,235	42,528	30,221
Reference price ²	3.550	6.320	5.130	5.700	4.450	4.350	4.350	4.350
Nbr of stocks (in thousands)	6,282,510	6,282,510	6,282,510	6,282,510	6,282,510	6,282,510	-	-
Announcement Date	29/03/22	30/03/23	26/03/24	26/03/25	24/03/26	-	-	-

¹HKD in Million²HKD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED	5.58x	0.23x	3.81x	4.68%	3.48B
ELI LILLY AND COMPANY	32.78x	11.92x	24.16x	0.6%	1,028B
JOHNSON & JOHNSON	30.03x	6.68x	18.7x	1.99%	651B
ABBVIE INC.	33.38x	7.81x	16.15x	2.6%	466B
ROCHE HOLDING AG	19.33x	4.72x	11.71x	2.81%	346B
NOVARTIS AG	19.72x	5.16x	12.79x	3.11%	266B
ASTRAZENECA PLC	21.26x	4.42x	12.58x	1.99%	259B
AMGEN INC.	24.43x	6.42x	11.43x	2.62%	208B
NOVO NORDISK A/S	12.52x	4.56x	9.46x	4.01%	191B
GILEAD SCIENCES, INC.	-45.4x	6.61x	25.81x	2.19%	186B
Average	15.36x	5.85x	14.66x	2.66%	360.52B
Weighted average by Cap.	23.66x	7.72x	17.82x	1.99%